• Exchange: Natl India
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

KOP:IN

65.15 INR 0.10 0.15%

As of 07:06:08 ET on 09/02/2014.

Snapshot for Kopran Ltd (KOP)

Open: 65.55 Day's Range: 64.40 - 67.40 Volume: 3,120,489
Previous Close: 65.05 52wk Range: 13.55 - 67.40 1-Yr Rtn: +360.42%

Stock Chart for KOP

No chart data available.
  • KOP:IN 65.15
  • 1D
  • 1M
  • 1Y
65.05
Interactive KOP Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for KOP

Current P/E Ratio (ttm) 14.8068
Estimated P/E(-) -
Relative P/E vs. SENSEX 0.7922
Earnings Per Share (ttm) 4.4000
Est. EPS -
Est. PEG Ratio -
Market Cap (M INR) 2,544.28
Shares Outstanding (M) 39.05
30 Day Average Volume 1,794,833
Price/Book (mrq) 2.2208
Price/Sale (ttm) 0.8623
Dividend Indicated Gross Yield -%
Cash Dividend (INR) 1.7963
Dividend Ex-Date 09/11/2000
5 Year Dividend Growth -
Next Earnings Announcement 05/28/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for KOP

  • Revenue
  • Net Income (M/INR)
  • Profit Margin (%)

Company Profile & Key Executives for KOP

Kopran Ltd. manufactures pharmaceutical products, bulk drugs and formulations, in addition to marketing state of the art electronic medical equipment. The Company's products include semi synthetic penicillin and antibiotic bulk drugs, including ampicillin trihydrate, cloxacillin sodium, rifampicin, amoxicillin trihydrate and cephalexin monohydrate.

Surendra SomaniVice ChairmanAjit JainCOO/Executive Director
Sunil SodhaniSecretary/Compliance Officer
More Company Profile & Key Executives for KOP

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil